BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Phytomedics, Inc. 

2245 Route 130, Suite 103

Dayton  New Jersey  08810  U.S.A.
Phone: 732-274-0080 Fax: 732-274-0067


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Phytomedics, Inc. to Present at 2010 New York Venture Summit 6/16/2010 11:48:40 AM
Dr. Jacques-Pierre Moreau Joins Phytomedics, Inc. Board of Directors 6/7/2010 11:31:33 AM
Phytomedics, Inc. To Present at Biotechnology Industry Organization (BIO) 2010 International Convention 4/28/2010 12:10:27 PM
Phytomedics, Inc. Testing TCM Drug for Rheumatoid Arthritis 9/18/2008 1:20:35 PM
Phytomedics, Inc. Appoints New President and Chief Executive Officer 4/16/2008 7:59:55 AM
Phytomedics, Inc. to Present at Wachovia 2008 Healthcare Conference 1/28/2008 10:05:21 AM
Phytomedics, Inc. Announces that Arthur H. Finnel Will Join Its Senior Management Team as Chief Financial Officer 7/27/2007 11:11:37 AM
Phytomedics, Inc. Announces Arthur H. Finnel Will Join Its Senior Management Team as Chief Financial Officer 7/26/2007 11:22:48 AM
Phytomedics, Inc. Announces Series B Funding of US $9 Million to Start Development of its Phase III Drug Candidate for Rheumatoid Arthritis 6/11/2007 12:33:23 PM
Phytomedics, Inc.'s Novel Oral Disease Modifying Drug Candidate PMI-001 Demonstrates Positive Phase II Results In Rheumatoid Arthritis 11/28/2006 8:44:18 AM
12